Cohort A (n = 70) | Cohort B (n = 79) | Significance (p-value) | |
---|---|---|---|
Normal | 45 (64.2%) | 69 (87.3%) | 0.0009 |
LV dysfunction | 2 (2.9%) | 3 (3.8%) | 0.75 |
Regional wall motion abnormalities | 3 (4.3%) | 4 (5.1%) | 0.82 |
Valvular heart disease (≥ mild) | 11 (15.7%) | 2 (2.5%) | 0.004 |
Diastolic dysfunction | 8 (11.4%) | 0 (0%) | 0.002 |
Pulmonary hypertension | 3 (4.3%) | 2 (2.5%) | 0.55 |
Other | 1 (1.4%) | 2 (2.5%) | 0.63 |